Eligibility and safety of triple therapy for hepatitis C: lessons learned from the first experience in a real world setting.

by Benjamin Maasoumy, Kerstin Port, Antoaneta Angelova Markova, Beatriz Calle Serrano, Magdalena Rogalska-Taranta, Lisa Sollik, Carola Mix, Janina Kirschner, Michael P Manns, Heiner Wedemeyer, Markus Cornberg
Published 2013-01-01